Skip to content

IOS Parameters and PAP Titration Pressure in Obstructive Sleep Apnea

Impulse Oscillometry for Prediction of PAP Titration Pressure in Obstructive Sleep Apnea (IOS-PAP Study)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07554430
Acronym
IOS-PAP
Enrollment
92
Registered
2026-04-28
Start date
2026-05-01
Completion date
2027-01-02
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea (OSA)

Keywords

obstructive sleep apnea, positive airway pressure, cpap, bpap

Brief summary

This prospective observational study aims to investigate whether impulse oscillometry (IOS)-a non-invasive lung function test-can help predict the specific pressure settings needed for positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA). Currently, finding the optimal therapeutic pressure for OSA patients typically requires a titration process during sleep. This study explores if IOS parameters, which measure airway resistance and elasticity through small pressure oscillations during normal breathing, correlate with the final titration pressures (CPAP, EPAP, IPAP, and ΔP) determined by polysomnography. Adult patients diagnosed with moderate-to-severe OSA (Apnea-Hypopnea Index ≥ 15) will undergo standard diagnostic sleep testing followed by IOS testing using the Vyaire Vyntus BodyBox® system. The researchers will evaluate whether these respiratory measurements can accurately predict required airway pressures and if they can help clinicians distinguish between patients who need Continuous Positive Airway Pressure (CPAP) versus Bilevel Positive Airway Pressure (BPAP) therapy.

Interventions

None listed

Sponsors

Mustafa Kemal University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 80 years * Diagnosed with obstructive sleep apnea (OSA) by overnight polysomnography (PSG) * Apnea-hypopnea index (AHI) ≥ 15 * Undergoing positive airway pressure (PAP) titration (CPAP or BPAP) * Able to perform impulse oscillometry (IOS) test * Provided written informed consent

Exclusion criteria

* Central sleep apnea * Neuromuscular disease or restrictive lung disease * Recent upper airway infection (\< 2 weeks) * Incomplete PSG or IOS data * Inability to cooperate with testing procedures

Design outcomes

Primary

MeasureTime frameDescription
Correlation between baseline impulse oscillometry (IOS) parameters (R5, X5, and Fres) and optimal CPAP pressure.From baseline IOS measurement to completion of the overnight titration study (assessed up to 4 weeks)Evaluating the relationship between specific lung function parameters-specifically total airway resistance (R5), reactance (X5), and resonant frequency (Fres)-measured by a daytime IOS session, and the effective Continuous Positive Airway Pressure (CPAP) determined during the subsequent overnight titration study.

Secondary

MeasureTime frameDescription
Discriminative ability of IOS parameters for CPAP versus BPAP treatment allocation.From baseline IOS measurement to completion of the overnight titration study (assessed up to 4 weeks).Assessing whether baseline impulse oscillometry parameters (R5, X5, Fres, AX) can predict if a patient will require Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BPAP) therapy. This will be evaluated using the Area Under the Receiver Operating Characteristic (ROC) Curve.
Correlation between baseline IOS reactance parameters and bilevel pressure settings (IPAP/EPAP).From baseline IOS measurement to completion of the overnight titration study (assessed up to 4 weeks).Assessing whether baseline impulse oscillometry parameters can predict the specific Inspiratory Positive Airway Pressure (IPAP) and Expiratory Positive Airway Pressure (EPAP) levels required for Bilevel Positive Airway Pressure (BPAP) therapy. This will be evaluated using the correlation coefficient.

Countries

Turkey (Türkiye)

Contacts

CONTACTKadir Burak Akgün, Assistant Professor
kadirburakakgun@gmail.com+905448127828

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026